Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 5/20 | 0.69 |
| ▸ | RAB9A | P51151 | 4/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
| ▸ | CRHBP | P24387 | 1/20 | 0.69 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | FAAH | O00519 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7565510 | 0.89 | RAB9A (0.71) | LMNACYP1A2POLBNPC1RAB9A | |
| SCHEMBL9188320 | 0.87 | HPGD (0.87) | LMNACYP1A2POLBNPC1RAB9A | |
| SCHEMBL2091634 | 0.87 | CYP1A2 (0.71) | LMNAKMT2ACYP1A2MEN1POLB | |
| SCHEMBL9377448 | 0.87 | NPC1 (0.61) | LMNAKMT2ACYP1A2MEN1POLB | |
| SCHEMBL7556396 | 0.86 | NPC1 (0.69) | LMNAKMT2ACYP1A2NPC1RAB9A | |
| SCHEMBL10461347 | 0.85 | NPC1 (0.60) | LMNAKMT2ACYP1A2MEN1POLB | |
| SCHEMBL27887839 | 0.85 | FAAH (0.67) | NPC1RAB9AHPGDCRHBPCRHR2 | |
| SCHEMBL4189931 | 0.85 | KMT2A (0.73) | LMNAKMT2ACYP1A2MEN1POLB | |
| SCHEMBL10460392 | 0.84 | NPC1 (0.58) | LMNAKMT2AMEN1NPC1RAB9A | |
| SCHEMBL9702872 | 0.84 | FAAH (0.69) | FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115210310-B | Compositions and methods for waste polypropylene degradation | 诺弗洛普有限公司 | 2024-08-30 | — | — | CN | claimed |
| US-11840610-B2 | Compositions and methods for the degradation of waste polypropylene | NOVOLOOP, INC. (US) | 2023-12-12 | — | — | US | claimed |
| CN-115210310-A | Composition and method for waste polypropylene degradation | 诺弗洛普有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115210310-B | Compositions and methods for waste polypropylene degradation | 诺弗洛普有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-115210310-A | Composition and method for waste polypropylene degradation | 诺弗洛普有限公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20150353738-A1 | COATING AGENT | NIPPON SODA CO., LTD. (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-0302422-B1 | Urea derivatives | KYORIN SEIYAKU KK (JP) | 1993-12-08 | — | — | EP | disclosed |
| US-5077302-A | Antiulcer agents | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1991-12-31 | — | — | US | disclosed |
| US-4952591-A | HISTAMINE H2-ANTAGONISTS | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0302422-A2 | Urea derivatives | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1989-02-08 | — | — | EP | disclosed |
| US-4600797-A | NITRATING AN AMINOBENZENE WHICH HAS A PROTECTEDD AMINO GROUP | BAYER AKTIENGESELLSCHAFT (DE) | 1986-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353738-A1 | COATING AGENT | ITGA1, ITGA2, L1CAM | LMNA 1185/4885KMT2A 741/4885CYP1A2 1970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.